健神利水方对脑出血大鼠p38 MAPK表达的影响
Effect of Jianshen Lishui Decoction on p38 MAPK Expression in Rats with Cerebral Hemorrhage
DOI: 10.12677/tcm.2024.137250, PDF,    科研立项经费支持
作者: 农凤兰*:广西中医药大学研究生院,广西 南宁;何乾超:广西中医药大学第一附属医院脑病科一区,广西 南宁;高玉广#:广西中医药大学第一附属医院急诊科,广西 南宁
关键词: 脑出血p38丝裂原活化蛋白激酶健神利水方反转录聚合酶链式反应Cerebral Hemorrhage p38 Mitogen-Activated Protein Kinase Jianshen Lishui Decoction Reverse Transcription Polymerase Chain Reaction
摘要: 目的:探究健神利水方对脑出血大鼠p38丝裂原活化蛋白激酶(p38 Mitogen-Activated Protein Kinase, p38 MAPK)表达的影响。方法:将50只SD大鼠随机分为假手术组(n = 10)和脑出血模型组(n = 40),采用胶原酶制作脑出血大鼠模型,假手术组以等量生理盐水代替胶原酶造模;造模成功后,脑出血模型组随机均分为脑出血组(n = 10)、健神利水方低剂量组(n = 10)、健神利水方中剂量组(n = 10)及健神利水方高剂量组(n = 10) 4个组。其中,假手术组和脑出血组以等量生理盐水灌胃,健神利水方低、中、高剂量组分别以等量低、中、高剂量健神利水方灌胃,连续灌胃7天;采用Longa评分法对大鼠的神经功能进行评分;取大鼠脑组织,采用蛋白免疫印迹法(Western Blot, WB)检测p38 MAPK表达,采用反转录聚合酶链式反应(RT-PCR)检测大鼠脑组织p38 MAPK的mRNA表达水平。最后用统计软件SPSS 25.0对数据进行统计分析。结果:脑出血组较假手术组Longa评分、p38 MAPK、p38 MAPK的mRNA表达水平均显著升高(均P < 0.01);低剂量组较脑出血组Longa评分、p38 MAPK、p38 MAPK的mRNA表达水平均升高(均P < 0.05);中剂量组较低剂量组p38 MAPK、p38 MAPK的mRNA表达水平均升高(均P < 0.05);高剂量组较中剂量组p38 MAPK、p38 MAPK的mRNA表达水平均升高(均P < 0.05)。结论:健神利水方能有效改善脑出血大鼠的神经损伤症状,其作用机制与抑制p38 MAPK的表达相关。
Abstract: Objective: To explore the effect of Jianshen Lishui decoction on the expression of p38 Mitogen-Activated Protein Kinase (p38 MAPK) in rats with cerebral hemorrhage. Methods: Fifty SD rats were randomly divided into sham operation group (n = 10) and cerebral hemorrhage model group (n = 40). The cerebral hemorrhage rat model was made with collagenase, and the sham operation group was made with the same amount of normal saline instead of collagenase. After the successful modeling, the cerebral hemorrhage model group was randomly divided into 4 groups: cerebral hemorrhage group (n = 10), Jianshen Lishui decoction prescription low-dose group (n = 10), Jianshen Lishui decoction prescription medium-dose group (n = 10) and Jianshen Lishui decoction prescription high-dose group (n = 10). Among them, sham operation group and cerebral hemorrhage group were given the same amount of normal saline, while Jianshen Lishui decoction prescription low-, medium- and high-dose groups were given the same amount of low-, medium- and high-dose of Jianshen Lishui decoction prescription, respectively, for continuous 7 days. The neural function of rats was evaluated by Longa score. The expression of p38 MAPK in rat brain tissues was detected by Western Blot (WB), and the mRNA expression level of p38 MAPK in rat brain tissues was detected by Reverse Transcription Polymerase Chain Reaction (RT-PCR). Finally, statistical software SPSS 25.0 was used to analyze the data. Results: Compared with sham operation group, Longa score, p38 MAPK and p38 MAPK mRNA expression levels in cerebral hemorrhage group were significantly increased (all P < 0.01). Compared with cerebral hemorrhage group, Longa score, p38 MAPK and p38 MAPK mRNA expression levels in low-dose group were increased (all P < 0.05). The mRNA expression levels of p38 MAPK and p38 MAPK in medium dose group were increased compared with those in low dose group (all P < 0.05). The mRNA expression levels of p38 MAPK and p38 MAPK in high-dose group were higher than those in medium-dose group (all P < 0.05). Conclusion: Jianshen Lishui decoction can effectively improve the symptoms of nerve injury in rats with cerebral hemorrhage, and its mechanism is related to inhibiting the expression of p38 MAPK.
文章引用:农凤兰, 何乾超, 高玉广. 健神利水方对脑出血大鼠p38 MAPK表达的影响[J]. 中医学, 2024, 13(7): 1626-1634. https://doi.org/10.12677/tcm.2024.137250

参考文献

[1] World Health Organization (2020) The Top 10 Causes of Death.
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
[2] Naghavi, M., Abajobir, A.A., Abbafati, C., Abbas, K.M., Abd-Allah, F., Abera, S.F., et al. (2017) Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980-2016: A Systematic Analysis for the Global Burden of Disease Study 2016. The Lancet, 390, 1151-1210. [Google Scholar] [CrossRef] [PubMed]
[3] Zhou, M., Wang, H., Zhu, J., Chen, W., Wang, L., Liu, S., et al. (2016) Cause-Specific Mortality for 240 Causes in China during 1990-2013: A Systematic Subnational Analysis for the Global Burden of Disease Study 2013. The Lancet, 387, 251-272. [Google Scholar] [CrossRef] [PubMed]
[4] Feigin, V.L., Forouzanfar, M.H., Krishnamurthi, R., Mensah, G.A., Connor, M., Bennett, D.A., et al. (2014) Global and Regional Burden of Stroke during 1990-2010: Findings from the Global Burden of Disease Study 2010. The Lancet, 383, 245-255. [Google Scholar] [CrossRef] [PubMed]
[5] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019) [J]. 中华神经科杂志, 2019, 52(12): 994-1005.
[6] Garg, R. and Biller, J. (2019) Recent Advances in Spontaneous Intracerebral Hemorrhage. F1000Research, 8, Article No. 302. [Google Scholar] [CrossRef] [PubMed]
[7] Gross, B.A., Jankowitz, B.T. and Friedlander, R.M. (2019) Cerebral Intraparenchymal Hemorrhage. JAMA, 321, 1295-1303. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, D., Liu, J., Liu, M., Lu, C., Brainin, M. and Zhang, J. (2017) Patterns of Stroke between University Hospitals and Nonuniversity Hospitals in Mainland China: Prospective Multicenter Hospital-Based Registry Study. World Neurosurgery, 98, 258-265. [Google Scholar] [CrossRef] [PubMed]
[9] Gu, H., Li, Z., Zhao, X., Liu, L., Li, H., Wang, C., et al. (2018) Insurance Status and 1-Year Outcomes of Stroke and Transient Ischaemic Attack: A Registry-Based Cohort Study in China. BMJ Open, 8, e021334. [Google Scholar] [CrossRef] [PubMed]
[10] Zhou, J., Zhang, Y., Arima, H., Zhao, Y., Zhao, H., Zheng, D., et al. (2014) Sex Differences in Clinical Characteristics and Outcomes after Intracerebral Haemorrhage: Results from a 12-Month Prospective Stroke Registry in Nanjing, China. BMC Neurology, 14, Article No. 172. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, J., Wang, D., Yuan, R., Xiong, Y. and Liu, M. (2016) Prognosis of 908 Patients with Intracerebral Hemorrhage in Chengdu, Southwest of China. International Journal of Neuroscience, 127, 586-591. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, W., Jiang, B., Sun, H., Ru, X., Sun, D., Wang, L., et al. (2017) Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation, 135, 759-771. [Google Scholar] [CrossRef] [PubMed]
[13] Guan, T., Ma, J., Li, M., Xue, T., Lan, Z., Guo, J., et al. (2017) Rapid Transitions in the Epidemiology of Stroke and Its Risk Factors in China from 2002 to 2013. Neurology, 89, 53-61. [Google Scholar] [CrossRef] [PubMed]
[14] 高玉广, 黄德庆, 刘泰, 等. 健神利水方对脑出血大鼠水通道蛋白AQP-4表达的影响[J]. 中国民族民间医药, 2021, 30(5): 17-20.
[15] 高玉广, 黄德庆, 刘泰, 等. 健神利水方对急性脑出血患者C反应蛋白、降钙素原的影响研究[J]. 海南医学院学报, 2021, 27(13): 978-982.
[16] Li, X., Huang, X., Tang, Y., Zhao, F., Cao, Y., Yin, L., et al. (2018) Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models. Frontiers in Pharmacology, 9, Article 1169. [Google Scholar] [CrossRef] [PubMed]
[17] 陈炜, 黄树武, 高玉广, 等. 健神利水颗粒对脑出血大鼠神经功能损害及神经元细胞凋亡的影响[J]. 药学研究, 2015, 34(9): 497-499, 516.
[18] 刘双岭, 孔菲, 刘刚, 等. 脑出血后脑损伤病理机制的研究进展[J]. 医学综述, 2020, 26(14): 2807-2813.
[19] Arthur, J.S.C. and Ley, S.C. (2013) Mitogen-Activated Protein Kinases in Innate Immunity. Nature Reviews Immunology, 13, 679-692. [Google Scholar] [CrossRef] [PubMed]
[20] 张晓璇, 马征, 于宁, 等. 丁苯酞对缺血性脑卒中大鼠海马神经元凋亡的抑制作用及其对p38 MAPK信号通路的影响[J]. 吉林大学学报(医学版), 2019, 45(5): 1086-1091.
[21] 谢君, 张智博. 细胞内丝裂原活化蛋白激酶信号通路与脑缺血后神经元凋亡[J]. 国际脑血管病杂志, 2015, 23(6): 464-468.
[22] Yao, L., Zhu, Z., Wu, J., Zhang, Y., Zhang, H., Sun, X., et al. (2019) MicroRNA‐124 Regulates the Expression of p62/p38 and Promotes Autophagy in the Inflammatory Pathogenesis of Parkinson’s Disease. The FASEB Journal, 33, 8648-8665. [Google Scholar] [CrossRef] [PubMed]
[23] 丁志敏, 高静, 苏凯奇, 等. p38 MAPK信号通路在脑卒中后认知障碍中的作用及在中药防治中的药理研究进展[J]. 中国药房, 2022, 33(8): 1014-1020.
[24] Falcicchia, C., Tozzi, F., Arancio, O., Watterson, D.M. and Origlia, N. (2020) Involvement of p38 MAPK in Synaptic Function and Dysfunction. International Journal of Molecular Sciences, 21, Article 5624. [Google Scholar] [CrossRef] [PubMed]
[25] Asih, P.R., Prikas, E., Stefanoska, K., Tan, A.R.P., Ahel, H.I. and Ittner, A. (2020) Functions of p38 MAP Kinases in the Central Nervous System. Frontiers in Molecular Neuroscience, 13, Article 570586. [Google Scholar] [CrossRef] [PubMed]
[26] Zhou, W.J., Gui, Q.F., Wu, Y., et al. (2015) Tanshinone IIA Protects against Methylglyoxal-Induced Injury in Human Brain Microvascular Endothelial Cells. International Journal of Clinical and Experimental Medicine, 8, 1985-1992.
[27] Chen, W., Guo, S., Li, X., Song, N., Wang, D. and Yu, R. (2020) The Regulated Profile of Noncoding Rnas Associated with Inflammation by Tanshinone IIA on Atherosclerosis. Journal of Leukocyte Biology, 108, 243-252. [Google Scholar] [CrossRef] [PubMed]
[28] 李丹, 徐沙丽, 周志林. 基于p38 MAPK/Drosha信号通路探讨脑出血患者继发性脑损伤及神经细胞凋亡的机制[J]. 华南国防医学杂志, 2021, 35(11): 786-791, 795.
[29] 董西朝, 王林林, 张亮, 等. 烟酰胺经调控p38 MAPK信号通路对高血压脑出血大鼠的脑保护作用机制分析[J]. 现代生物医学进展, 2023, 23(18): 3431-3435, 3444.
[30] 杨树升, 林丽. 大承气汤对脑出血模型大鼠小胶质细胞的作用及机制探讨[J]. 华中科技大学学报(医学版), 2021, 50(6): 728-733, 749.
[31] 朝博, 任君浩, 苏优勒. 塞来昔布通过MAPK/ERK信号通路抑制炎症反应改善急性脑出血大鼠神经功能的机制研究[J]. 中国药师, 2023, 26(11): 181-188.